arrow_back Trending Legislation
Share share

Protecting Pharmacies in Medicaid: Transparent Drug Payments

This act aims to ensure pharmacies receive fair payments for drugs under Medicaid and to prevent unfair pricing practices. This means drug prices will be more transparent, potentially impacting the stability of drug access and pharmacy services for Medicaid beneficiaries.
Key points
Introduces monthly surveys of pharmacy drug prices to determine national average acquisition costs, ensuring fair payments.
Pharmacies must respond to price surveys; refusal or false information can result in civil penalties up to $100,000.
Prohibits abusive "spread pricing" where intermediaries take excessive margins, ensuring funds reach pharmacies.
Increases oversight of drug payments in Medicaid, including how pharmacy benefit managers handle reimbursements to pharmacies.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Introduced
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Protecting Pharmacies in Medicaid Act
Print number: S 927
Sponsor: Sen. Welch, Peter [D-VT]
Process start date: 2025-03-11
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Protecting Pharmacies in Medicaid: Transparent Drug Payments

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 927.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-03-11.

What are the main provisions?

Key points include:

  • Introduces monthly surveys of pharmacy drug prices to determine national average acquisition costs, ensuring fair payments.
  • Pharmacies must respond to price surveys; refusal or false information can result in civil penalties up to $100,000.
  • Prohibits abusive "spread pricing" where intermediaries take excessive margins, ensuring funds reach pharmacies.
  • Increases oversight of drug payments in Medicaid, including how pharmacy benefit managers handle reimbursements to pharmacies.

What is the specific legal status?

The current status is Introduced.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Welch, Peter [D-VT].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

Analysis and Potential Impact of S 927

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health